Exactech

Exactech, Inc. ("Exactech") is a Gainesville, Florida-based orthopedic medical device company founded in 1985 by orthopedic surgeon Dr. Bill Petty, his wife Betty Petty, and biomedical engineer Gary Miller. It was publicly traded on Nasdaq (EXAC) until February 2018, when TPG Capital acquired it for roughly $737 million; it thereafter operated under holding company Osteon Holdings, Inc. Reported revenue was about $258 million in 2016 and roughly $264 million for the trailing four quarters ending September 30, 2017, with headcount generally reported in the 700–900 range.

Exactech develops and manufactures joint replacement implants and related surgical instruments for hip, knee, shoulder, and ankle reconstruction, along with bone cement and biologic materials. Named product lines include the Equinoxe Shoulder, Vantage Ankle, Alteon and Spartan Hip, and Truliant, Triverse, and Newton Knee systems, plus ExactechGPS computer-assisted navigation and the Active Intelligence technology platform. It operates manufacturing facilities in Gainesville and Sarasota, Florida, and Gières, France.

Litigation posture: Exactech is an operating company, not a patent assertion entity. In the case data it appears only as a defendant (0 plaintiff cases, 1 defendant case), consistent with a product manufacturer being sued on third-party patents rather than asserting its own. The single tracked suit, Conformis, Inc. v. Bodycad et al. (M.D. Fla., filed June 3, 2021), was brought by Conformis, Inc. The venue is the Middle District of Florida — Exactech's home district — not a plaintiff-friendly venue such as the Eastern District of Texas.

Context: The Conformis complaint accused Bodycad's Reflex Uni unicondylar knee system and Fine Osteotomy guide of infringing patient-specific implant patents; Exactech was named as the U.S. distributor of the Reflex Uni system under the name Truliant Reflex Uni (a separate, related Conformis complaint targeted Exactech's Vantage Total Ankle System). Separately, Exactech filed Chapter 11 in Delaware in October 2024 amid roughly 2,600 lawsuits over recalled implants, and emerged on October 31, 2025 under new ownership comprising Strategic Value Partners, Stellex Capital Management, and Greywolf Capital Management.